-
Tamoxifen shown to reduce breast cancer recurrence for women with early stage disease
Madely Health Headlines Commentary for August 2, 2011 [display_podcast] Source: Tamoxifen Legacy Lasts Long Term Reference: Early Breast Cancer Trialists’ Collaborative Group “Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials” Lancet 2011; DOI: 10.1016/S0140-6736(11)60993-8.
-
Estrogen-sensitive breast cancer risk reduction study finds two drugs that work but have trade-offs
Madely Health Headlines Commentary for April 20, 2010 [display_podcast] Source: Older Drug Cuts Breast-Cancer Risk More
-
Paxil interferes with tamoxifen's efficacy combating breast cancer/Sunday House Call returns to the airwaves
Madely Health Headlines Commentary for February 10, 2010 [display_podcast] Source: Paxil, Tamoxifen May Be a Risky Combo Reference: Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study